These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7892041)

  • 21. Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis.
    de Leon MP; Pedroni M; Benatti P; Percesepe A; Di Gregorio C; Foroni M; Rossi G; Genuardi M; Neri G; Leonardi F; Viel A; Capozzi E; Boiocchi M; Roncucci L
    Gut; 1999 Jul; 45(1):32-8. PubMed ID: 10369701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer.
    Hemminki A; Peltomäki P; Mecklin JP; Järvinen H; Salovaara R; Nyström-Lahti M; de la Chapelle A; Aaltonen LA
    Nat Genet; 1994 Dec; 8(4):405-10. PubMed ID: 7894494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of G2-phase chromosomal radiosensitivity in hereditary non-polyposis colorectal cancer cells.
    Franchitto A; Pichierri P; Genuardi M; De Santis A; Palitti F
    Int J Radiat Biol; 2001 Jul; 77(7):773-80. PubMed ID: 11454277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
    Johnson V; Volikos E; Halford SE; Eftekhar Sadat ET; Popat S; Talbot I; Truninger K; Martin J; Jass J; Houlston R; Atkin W; Tomlinson IP; Silver AR
    Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.
    Loughrey MB; Waring PM; Tan A; Trivett M; Kovalenko S; Beshay V; Young MA; McArthur G; Boussioutas A; Dobrovic A
    Fam Cancer; 2007; 6(3):301-10. PubMed ID: 17453358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The natural history of a combined defect in MSH6 and MUTYH in a HNPCC family.
    van Puijenbroek M; Nielsen M; Reinards TH; Weiss MM; Wagner A; Hendriks YM; Vasen HF; Tops CM; Wijnen J; van Wezel T; Hes FJ; Morreau H
    Fam Cancer; 2007; 6(1):43-51. PubMed ID: 17039270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of colonic and endometrial carcinomas in Portuguese families with hereditary nonpolyposis colorectal carcinoma significantly increases the probability of detecting a pathogenic mutation in mismatch repair genes, primarily the MSH2 gene.
    Lage PA; Albuquerque C; Sousa RG; Cravo ML; Salazar M; Francisco I; Maia L; Claro I; Suspiro A; Rodrigues P; Raposo H; Fidalgo PA; Nobre-Leitão C
    Cancer; 2004 Jul; 101(1):172-7. PubMed ID: 15222003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene.
    Shin KH; Shin JH; Kim JH; Park JG
    Cancer Res; 2002 Jan; 62(1):38-42. PubMed ID: 11782355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hereditary non-polyposis colorectal cancer and the role of hPMS2 and hEXO1 mutations.
    Thompson E; Meldrum CJ; Crooks R; McPhillips M; Thomas L; Spigelman AD; Scott RJ
    Clin Genet; 2004 Mar; 65(3):215-25. PubMed ID: 14756672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis.
    Pedroni M; Sala E; Scarselli A; Borghi F; Menigatti M; Benatti P; Percesepe A; Rossi G; Foroni M; Losi L; Di Gregorio C; De Pol A; Nascimbeni R; Di Betta E; Salerni B; de Leon MP; Roncucci L
    Cancer Res; 2001 Feb; 61(3):896-9. PubMed ID: 11221877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree.
    Wagner A; Hendriks Y; Meijers-Heijboer EJ; de Leeuw WJ; Morreau H; Hofstra R; Tops C; Bik E; Bröcker-Vriends AH; van Der Meer C; Lindhout D; Vasen HF; Breuning MH; Cornelisse CJ; van Krimpen C; Niermeijer MF; Zwinderman AH; Wijnen J; Fodde R
    J Med Genet; 2001 May; 38(5):318-22. PubMed ID: 11333868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual role of LOH at MMR loci in hereditary non-polyposis colorectal cancer?
    Sanchez de Abajo A; de la Hoya M; van Puijenbroek M; Godino J; Díaz-Rubio E; Morreau H; Caldes T
    Oncogene; 2006 Mar; 25(14):2124-30. PubMed ID: 16288214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).
    Hendriks YM; Jagmohan-Changur S; van der Klift HM; Morreau H; van Puijenbroek M; Tops C; van Os T; Wagner A; Ausems MG; Gomez E; Breuning MH; Bröcker-Vriends AH; Vasen HF; Wijnen JT
    Gastroenterology; 2006 Feb; 130(2):312-22. PubMed ID: 16472587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible role of telomerase activation in the cancer predisposition of patients with hereditary nonpolyposis colorectal cancers.
    Cheng AJ; Tang R; Wang JY; See LC; Wang TC
    J Natl Cancer Inst; 1998 Feb; 90(4):316-21. PubMed ID: 9486818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in molecular genetics of colorectal cancer.
    Baba S
    World J Surg; 1997 Sep; 21(7):678-87. PubMed ID: 9276697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
    Carethers JM; Stoffel EM
    World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees.
    Weber TK; Conlon W; Petrelli NJ; Rodriguez-Bigas M; Keitz B; Pazik J; Farrell C; O'Malley L; Oshalim M; Abdo M; Anderson G; Stoler D; Yandell D
    Cancer Res; 1997 Sep; 57(17):3798-803. PubMed ID: 9288790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Germline mutations of EXO1 gene in patients with hereditary nonpolyposis colorectal cancer (HNPCC) and atypical HNPCC forms.
    Wu Y; Berends MJ; Post JG; Mensink RG; Verlind E; Van Der Sluis T; Kempinga C; Sijmons RH; van der Zee AG; Hollema H; Kleibeuker JH; Buys CH; Hofstra RM
    Gastroenterology; 2001 Jun; 120(7):1580-7. PubMed ID: 11375940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hereditary non-polyposis colorectal cancer (HNPCC): new germline mutation (190-191 del AA) in the human MLH1 gene and review of clinical guidelines for surveillance of affected families.
    Schiemann U; Papatheodorou L; Glasl S; Gross M
    Eur J Med Res; 2001 Mar; 6(3):93-100. PubMed ID: 11309221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.